ScholarIQanswers from OpenAlex & ORCID
Pengfei Xu
ResearcherPublications, citations & collaboration network
Pengfei Xu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Pengfei Xu have?
ScholarIQindexed works
Pengfei Xu has 112 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Pengfei Xu have?
ScholarIQcitation count
Pengfei Xu has 1,591 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Pengfei Xu?
ScholarIQh-index
Pengfei Xu has an h-index of 22 in OpenAlex.
What is the i10-index of Pengfei Xu?
ScholarIQi10-index
Pengfei Xu has an i10-index of 40 in OpenAlex.
What is the ORCID of Pengfei Xu?
ScholarIQorcid
The ORCID for Pengfei Xu is on the source record.
What is the OpenAlex record for Pengfei Xu?
ScholarIQopenalex
The OpenAlex for Pengfei Xu is on the source record.
What are the most-cited papers on Pengfei Xu?
ScholarIQmost cited works
Allelopathic interactions of linoleic acid and nitric oxide increase the competitive ability of <i>Microcystis aeruginosa</i>
Hao Song, Michel Lavoie, Xiaoji Fan, Hana Tan, Guangfu Liu, Pengfei Xu, Zhengwei Fu, Hans W. Paerl, Haifeng Qian
Impact of copper nanoparticles and ionic copper exposure on wheat (Triticum aestivum L.) root morphology and antioxidant response
Zhenyan Zhang, Mingjing Ke, Qian Qu, Willie J.G.M. Peijnenburg, Tao Lu, Qi Zhang, Yizhi Ye, Pengfei Xu, Benben Du, Liwei Sun, Haifeng Qian
Analysis of COVID‐19 vaccines: Types, thoughts, and application
Xiucui Han, Pengfei Xu, Qing Ye
The role of S-nitrosylation of PFKM in regulation of glycolysis in ovarian cancer cells
Wenwen Gao, Mengqiu Huang, Xi Chen, Jianping Chen, Zhiwei Zou, Linlin Li, Kaiyuan Ji, Zhirui Nie, Bingsheng Yang, Zibo Wei, Pengfei Xu, Jun-Shuang Jia, Qianbing Zhang, Hong-Fen Shen, Qianli Wang, Keyi Li, Lingqun Zhu, Meng Wang, Shuangyan Ye, Sisi Zeng, Ying Lin, Zhili Rong, Yang Xu, Peng Zhu, Hui Zhang, Bingtao Hao, Qiuzhen Liu
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment
Pengfei Xu, Joy C. Yang, Bo Chen, Christopher Nip, Jonathan E Van Dyke, Xiong Zhang, Hongwu Chen, Christopher P. Evans, William J. Murphy, Chengfei Liu